Japan Biopharma
Partnering Conference

Conrad Hotel
Tokyo, Japan
October 25, 2016

About the Sponsors

Sofinnova Ventures

Founded in 1974, Sofinnova Ventures is a San Francisco Bay-Area based, internationally investing venture capital firm with over $1 billion under management. With a specialization in corporate spin-outs, we finance seed and early-stage companies developing pharmaceuticals and specialty pharmaceuticals. Our mission is to create value by providing entrepreneurs with the resources, experience and networks necessary to turn their ideas into profitable businesses. Sofinnova Ventures has offices in Menlo Park, San Francisco, and San Diego, California, as well as Tokyo, Japan.

Sofinnova Partners

Sofinnova Partners is an independent venture capital firm based in Paris, France. For over 35 years, the firm has backed nearly 500 companies at different stages of development – pure creations, spin-offs, as well as turnaround situations – and worked alongside Europe’s key entrepreneurs in the technology, life sciences and cleantech sectors. With €1.1 billion of funds under management, Sofinnova Partners’ experienced team and hands-on approach in building portfolio companies through to exit have created market leaders, from landmark historical investments including Genentech, Actelion and Vistaprint to more recent successes such as CoreValve, Novexel, Fovea and Sensitive Object. With a global mindset, the firm has a sister organization in San Francisco, California.


BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

Citigroup Global Markets Japan

Citigroup Global Markets Japan is a leading wholesale investment bank, offering a broad range of financial services, including investment banking, sales and trading and research. Drawing on the global expertise of Citi and its deep relationships in Japan, Citigroup Global Markets Japan offers its clients unparalleled global access and local expertise. Citi traces its origins in Japan to when the International Banking Corporation opened its first branch in Yokohama in 1902. Citigroup Global Markets Japan's own history includes a ten year partnership with Nikko Cordial Securities, through the joint venture Nikko Citigroup. Citigroup Global Markets Japan strives to leverage its leading position, on-going partnerships, the global network and unique strengths to be one of Japan's leading wholesale investment banks. Citigroup's global healthcare team covers 20 countries with 139 professional healthcare dedicated bankers, and has leading track record in M&As, equity and debt issuance, as well as loan syndications.

FinTech Global Capital

FinTech Global Capital (FGC) is a Tokyo based venture capital firm founded in 2006 by a team of accomplished investment professionals with extensive industry background. FGC is dedicated to investing in technology companies both in life sciences and information technology with strong Asian angle. The FGC team has established deep relationships with Asian pharmaceutical and technology companies allowing them to identify unique technology spin-out opportunities. FGC augments its core expertise of investing in spin-outs with the diverse expertise of its team in finance, marketing, business development and entrepreneurial management.

Mitsubishi UFJ Capital

Mitsubishi UFJ Capital Co., Ltd. is the venture capital arm of Mitsubishi UFJ Financial Group (MUFG), the largest financial group in Japan. Since 1974, we have supported many Japanese entrepreneurs. MUFG has many relationships within the Japanese pharmaceutical industry, and we hope our investments will contribute to their growth. Our Life Science Office is committed to supporting the industry on many fronts, from academic incubation to pharmaceutical clinical trial financing.

Mitsui Global Investment

Mitsui Global Investment (MGI) is the corporate venture capital arm of Mitsui & Co. Ltd., which is one of the largest business and investment houses in Japan. The firm’s investment focus has been on seed and early stage companies mainly in the life science and information technology sectors. We take an active role in our portfolio companies and work with management teams and our co-investors to create significant value.

MGI has offices in Silicon Valley, Tokyo, Beijing and Tel Aviv.

Omega Funds

Founded in 2004, Omega Funds is a dedicated global life sciences investment firm headquartered in Boston, with additional operations in London and San Francisco. Since its founding, the firm has raised $700M. At its inception, the firm specialized in direct secondary transactions providing total or partial liquidity to investors unable to follow on their original investment. Today, we are deploying Omega Fund V, a $300M fund investing directly in public and private companies, across all healthcare and life sciences sectors, including biotech, medical devices, diagnostics, services and healthcare IT. We also continue to provide customized solutions for investors seeking partial or complete liquidity for their shareholdings. Omega has a strong track record of identifying great management teams and companies and of backing them with capital, expertise and access to our network of relationships and resources, resulting in high-value exit outcomes.

Pillsbury Winthrop Shaw Pittman LLP

Pillsbury is a full-service law firm that guides life science and technology companies through every stage of their development, from incubating the idea to securing funding to IPO or exit and beyond. Entrepreneurs, venture capitalists, emerging growth companies and industry-leading multinationals rely on Pillsbury for advice on everything from financing and corporate governance to protecting and licensing intellectual property and cross-border acquisitions. The needs of Pillsbury’s clients are often international in scope. To meet those needs, Pillsbury’s U.S. and international offices form a fully integrated network that advises clients doing business around the globe. As a result, nearly one-third of our work touches overseas.

Wilson Sonsini Goodrich & Rosati

For more than 50 years, Wilson Sonsini Goodrich & Rosati has offered a broad range of services and legal disciplines focused on serving the principal challenges faced by the management and boards of directors of business enterprises. The firm is nationally recognized as a leader in the fields of corporate governance and finance, mergers and acquisitions, private equity, securities litigation, employment law, intellectual property, and antitrust, among many other areas of law. With deep roots in Silicon Valley, Wilson Sonsini Goodrich & Rosati has offices in Austin; Beijing; Boston; Brussels; Hong Kong; Los Angeles; New York; Palo Alto; San Diego; San Francisco; Seattle; Shanghai; Washington, D.C.; and Wilmington, DE.